Brief: Simcere Pharmaceutical Says Sanbexin Included In 2026 National Essential Medicines List
09/07/2026 16:18
BRIEF-Simcere Pharmaceutical Says Sanbexin Included In 2026 National Essential Medicines List July 9 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:
SANBEXIN INCLUDED IN 2026 NATIONAL ESSENTIAL MEDICINES LIST
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660